Abstract
This critique of the proposed FDA "Device Exemptions" (1978, Docket 76N-0324) analyses its defects, estimates the magnitude of device injury to patients during past 17 years, provides a prescription for rational FDA regulation under the present law, which is summarized and shown to allow FDA wide latitude in regulatory pressure; emphasizes the urgent need for properly trained engineers, which are not presently in or available to FDA; and estimates and predicts vast cost increases, competition suppression and blockade of new devices. The classification schema is shown to be illogical and capricious; the economic impact assessment faulty; and the law, extant regulations, proposed regulations complicated, confusing, and internally inconsistent.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
